CDMRP Glioblastoma Research Program: Transformative Consortium Award

The mission of the GBMRP is to promote rigorous, high-impact research to drive scientific discovery and advances in diagnosis, treatment, and quality of life for patients with glioblastoma. Within this context, the GBMRP is interested in supporting collaborative research that addresses specific gaps in glioblastoma research and clinical care. 

The consortium should have 4-5 teams working on discrete projects under a central hypothesis. Maximum 2 projects may be at the same institutions. See additional information in attached document. 

It is expected that 1 award will be granted.

Funding: $9,090,000
Duration: 4 years

Research Authority due date: 16.12.24

Pre proposal (required) due date: 23.12.24
Full proposal due date: 13.1.25